MedTrace Logo

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

NCT05286385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-02-07

Study results available
· View outcomes & findings →

Summary

This clinical study aims to investigate speech performance in quiet with an OTE Sound Processor with modified firmware compared with the commercially available CP1150. The study also investigates CP1110 and CP1150 with Forward Focus.

Conditions

  • Hearing Impairment, Sensorineural

Interventions

DEVICE

CP1150 Sound Processor

Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor

DEVICE

CP1150 NF

Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).

DEVICE

CP1150 + FF

Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.

DEVICE

CP1110

Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Cochlear

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-30
Primary Completion
2022-06-29
Completion
2022-06-29

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05286385 on ClinicalTrials.gov